The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zineryt 40 mg + 12 mg powder and solvent for cutaneous solution



CHEPLAPHARM Arzneimittel GmbHPA2239/018/001

Main Information

Trade NameZineryt 40 mg + 12 mg powder and solvent for cutaneous solution
Active SubstancesErythromycin
Zinc Acetate Dihydrate
Dosage FormPowder and solvent for cutaneous solution
Licence HolderCHEPLAPHARM Arzneimittel GmbH
Licence NumberPA2239/018/001

Group Information

ATC CodeD10AF Antiinfectives for treatment of acne
D10AF52 erythromycin, combinations

Status

License statusAuthorised
Licence Issued17/12/1992
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back